A sign of a (stock)tsunami is that the water(stock nav) rushes away from the shore, then comes back to higher levels...That is the first indication and then, the water begins rising fast taking out everything in its path. Stay short and ignore the signs of the coming tsunami, at to your own peril.
Your fact is only half of a fact! I have owned-up to the following:
Why dwell on the Apr 6, 2014 PR? Is that your job? More PRs came after that one, consistent with scale-up studies! Why? Our small company will not be afforded any shortcuts by the Federal Agencies that impose rules/requirements on small companies like NanoViricides, Inc., with First-in-Class drugs. In addition, before the Apr 16, 2014 PR, we read Mar 2014 CEO letter...
The CEO letter 2014, the Apr 6, 2014 and following PRs clearly state that 2014 was practically all about scale-up studies, and it all started at the old lab/existing facilities. You can thank the FDA for that.
Your referenced "juiced-up" competition, Ansun BioPharma (NexBio) Fludase is a First-in-Class drug, is it not? (Note: More than half (51%) of the NMEs approved in CY 2012 (20 of 39) were identified by FDA as First-in-Class, meaning drugs which, for example, use a new and unique mechanism of action for treating a medical condition.) Point this forum to the FDA pre clinical tox studies for NexBio - Fludase requirement to find the Maximum Feasible Dose or Toxic Dose. You should know this, should you not? Why not ask "Pumpy Terminator"/cabal, they should know about this.
NanoViricides, Inc. FluCide(TM), a First-in-Class drug as well, was required by the FDA to find the Maximum Feasible Dose, was it not? Knowing what we know about PEG + ligands, etc., where is the sense of proportionality in the FDA - U.S. Federal Agency requirements? Is it a "Yes we can" criteria? Moreover, the NIH has being funding NexBio, since its founding in 2003, to the tune of $73 million!!!
Where again is FDA's requirement for Ansun BioPharma (NexBio) Fludase, a First-in-Class drug, to conduct toxicology studies using MFD or to find the toxic dose? Why did your referenced "juiced up" competition defrauded de American Taxpayer funded NIH - U.S. Federal Agency?
Is NanoViricides, Inc. drug FluCide(TM) delayed? Compared to what other company with the same technology??? We have First-in-Class drugs.
Reiterating, what everyone should know about your "juiced-up" competition...
-A small-biotech that is privately-held -with Fludase a first-in-class Influenza drug -skids begin to get greased, for the small-biotech, Aug 8, 2005 -a 50m contract with the NIH, fast-tracked -Why would a privately-held company, that seems to have everything going for them, would feel the urge to defraud the United States of America/taxpayers funded NIH? Cash-flow problems? with a 50m biologic-contract, how can that be?
-If they had gone public in 2003 (or 2004) they would have likely taken off at the news they were funded by the NIH and crashed at the news that Ansun Biopharma had to pay $2 million for grant fraud and later on dismiss the CEO and his entire board of directors.
What do I take from all these news on Ansun Biopharma (NexBio) competition? NanoViricides, Inc. should receive north of $73 million from the NIH after Phase I clinical trials because, fair is fair! or better than that, poster "looneyforms - Dr Boniuk is selling NNVC shares???" will explain in detail, what criteria is employed by a Federal Agency like the National Institutes of Health (NIH) to award grants to any given company? Is that the "Yes we can" criteria or where is it written/printed?
Here is the FluCide(TM) preclinical data to help out:
NanoViricides, Inc. is no longer releasing news about "scale-up studies" and it is because... -we are done with scale-up studies, we have the 1Kg scale-up recipe for FluCide(TM) -we commissioned the new state-of-the-art multi-kilogram Pilot Plant in Shelton, CT, to produce FluCide(TM)/GLP, sometime in early Jan 2015 -Mar 31, 2015 - We are now progressing to a 1kg scale-up of FluCide, and enabling in-process control instrumentation--- CMC studies to enable further scale-up from the current multi-100g scale of production to kg-scale production. CMC stands for "Chemistry, Manufacture, and Controls," and relates to being able to make the drug substance and the drug product in a reproducible fashion, batch after batch. -We are now making the FluCide(TM) material for Phase III in large animals!
============================================
The beleaguered United States of America/taxpayers have an $18+ trillion dollar national debt, growing at the speed of compound interest on the debt, with federal unfunded liabilities exceeding $127 trillion and some still feel the urge to defraud?!?